Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial to Evaluate the Anti-inflammatory Effects of Empagliflozin Following PCI

NCT07292909 is registered in ClinicalTrials.gov with Hotel Dieu de France Hospital as lead sponsor.

NCT NCT07292909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07292909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial to Evaluate the Anti-inflammatory Effects of Empagliflozin Following PCI
Lead sponsor
Hotel Dieu de France Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
September 1, 2025
Completion date
September 30, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cad - coronary artery disease, inflamation, pci, sglt 2 inhibitors